Coronavirus: AstraZeneca will have 200 mln COVID-19 vaccines by end of 2020

A general view is pictured of the offices of British-Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca PLC in Macclesfield, Cheshire. (AFP)

AstraZeneca will have 200 million doses of its candidate vaccine developed by the University of Oxford by the end of 2020, with 700 million doses ready globally by the end of the first quarter of 2021, operations executive Pam Cheng said on Monday.

Cheng told a briefing that there would be 20 million doses in Britain by the end of the year, with 70 million doses for the UK by the end of Q1 2021.

Read the latest updates in our dedicated coronavirus section.

UK COVID-19 vaccine expected before Christmas, life ‘back to normal’ after Easter

China conducts millions of COVID-19 tests after flare-ups in 3 cities

AstraZeneca COVID-19 vaccine can be 90 pct effective, results show

SHOW MORE
Last Update: Monday, 23 November 2020 KSA 12:37 - GMT 09:37
Top